Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06260878
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-15
First Post:
2024-02-07
Brief Title:
Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis
Sponsor:
University of Calgary
Organization:
University of Calgary
Study Overview
Official Title:
Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
STRIPE
Brief Summary:
This study will explore the efficacies of several practical short-term peri-procedural intravenous fluid regimens in the prevention of post- endoscopic retrograde cholangiopancreatography ERCP pancreatitis PEP PEP is the most common serious ERCP-related adverse event AE occurring in 5-15 of patients and associated with significant morbidity mortality and healthcare utilization Given the current lack of data on effectiveness of short-term fluid regimens in PEP prevention to inform practice the results of the proposed study have the strong potential to impact ERCP practices worldwide whether positive or negative
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None